Clinical Trial Update: Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating psilocybin for major depressive disorder with co-occurring alcohol use disorder, sponsored by Johns Hopkins University;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Major Depressive Disorder, Alcohol Use Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING